The CDSCO has released a new circular on 1st June, 2021 for the approval of COVID-19 vaccines in Restricted Use. As per this rule, the requirement for conducting Post Approval and conducting testing for every batch can be exempted if they are approved for restricted use in US FDA, EMA, UK MHRA, PMDA Japan or listed in WHO Emergency Use Listing (EUL)
Source : CDSCO Gazette Notification
Leave a reply
You must be logged in to post a comment.